Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children.

Trial Profile

Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Aug 2009

At a glance

  • Drugs Linezolid; Linezolid
  • Indications Bacteraemia; Bacterial infections; Catheter infections; Nosocomial pneumonia; Skin infections; Vancomycin-resistant enterococcal infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 20 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top